# Kewaunee Scientific Corp: financial statements, quarterly

KEQU · Nasdaq · CIK 55529 · [Technology](/sectors/technology.md) · fiscal year ends Apr 30

Pages: [Overview](/companies/kequ.md) · [Financials](/companies/kequ/financials.md) · [Filings](/companies/kequ/filings.md) · [Insiders](/companies/kequ/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/kequ/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | Q4 FY2024 (2024-04-30) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | Q4 FY2025 (2025-04-30) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | Q4 FY2026 (2026-04-30) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [50.4](/filings/0000055529-24-000040.md) | [46.8](/filings/0000055529-25-000013.md) | [56.7 d](/filings/0000055529-25-000026.md) | [48.4](/filings/0000055529-25-000040.md) | [47.8](/filings/0000055529-25-000054.md) | [67.2](/filings/0000055529-26-000009.md) | [77.1 d](/filings/0000055529-26-000020.md) | [71.1](/filings/0000055529-26-000035.md) | [70.1](/filings/0000055529-25-000054.md) | [69.4](/filings/0000055529-26-000009.md) | [71.4 d](/filings/0000055529-26-000020.md) | [66.3](/filings/0000055529-26-000035.md) |
| Cost of revenue | $m | [37.0](/filings/0000055529-24-000040.md) | [34.7](/filings/0000055529-25-000013.md) | [42.1 d](/filings/0000055529-25-000026.md) | [35.9](/filings/0000055529-25-000040.md) | [33.8](/filings/0000055529-25-000054.md) | [48.8](/filings/0000055529-26-000009.md) | [53.1 d](/filings/0000055529-26-000020.md) | [50.2](/filings/0000055529-26-000035.md) | [50.4](/filings/0000055529-25-000054.md) | [50.9](/filings/0000055529-26-000009.md) | [50.2 d](/filings/0000055529-26-000020.md) | [46.7](/filings/0000055529-26-000035.md) |
| Gross profit | $m | [13.5](/filings/0000055529-24-000040.md) | [12.0](/filings/0000055529-25-000013.md) | [14.6 d](/filings/0000055529-25-000026.md) | [12.5](/filings/0000055529-25-000040.md) | [14.0](/filings/0000055529-25-000054.md) | [18.4](/filings/0000055529-26-000009.md) | [24.0 d](/filings/0000055529-26-000020.md) | [20.9](/filings/0000055529-26-000035.md) | [19.7](/filings/0000055529-25-000054.md) | [18.5](/filings/0000055529-26-000009.md) | [21.2 d](/filings/0000055529-26-000020.md) | [19.6](/filings/0000055529-26-000035.md) |
| Operating income | $m | [5.1](/filings/0000055529-24-000040.md) | [3.8](/filings/0000055529-25-000013.md) | [5.6 d](/filings/0000055529-25-000026.md) | [2.6](/filings/0000055529-25-000040.md) | [4.4](/filings/0000055529-25-000054.md) | [2.3](/filings/0000055529-26-000009.md) | [8.5 d](/filings/0000055529-26-000020.md) | [4.8](/filings/0000055529-26-000035.md) | [4.1](/filings/0000055529-25-000054.md) | [2.6](/filings/0000055529-26-000009.md) | [5.2 d](/filings/0000055529-26-000020.md) | [3.2](/filings/0000055529-26-000035.md) |
| Interest expense | $m | [0.4](/filings/0000055529-24-000040.md) | [0.4](/filings/0000055529-25-000013.md) | [0.6 d](/filings/0000055529-24-000021.md) | [0.5](/filings/0000055529-25-000040.md) | [0.4](/filings/0000055529-24-000040.md) | [1.1](/filings/0000055529-25-000013.md) | [1.2 d](/filings/0000055529-26-000020.md) | [1.1](/filings/0000055529-25-000040.md) | [1.1](/filings/0000055529-25-000054.md) | [1.1](/filings/0000055529-26-000009.md) | [0.6 d](/filings/0000055529-26-000020.md) | [0.6](/filings/0000055529-26-000035.md) |
| Income tax | $m | [2.0](/filings/0000055529-24-000040.md) | [1.0](/filings/0000055529-25-000013.md) | [(9.8) d](/filings/0000055529-25-000026.md) | [0.2](/filings/0000055529-25-000040.md) | [0.9](/filings/0000055529-25-000054.md) | [(0.1)](/filings/0000055529-26-000009.md) | [2.2 d](/filings/0000055529-26-000020.md) | [0.8](/filings/0000055529-26-000035.md) | [0.9](/filings/0000055529-25-000054.md) | [0.5](/filings/0000055529-26-000009.md) | [1.1 d](/filings/0000055529-26-000020.md) | [0.7](/filings/0000055529-26-000035.md) |
| Net income | $m | [2.7](/filings/0000055529-25-000013.md) | [2.5](/filings/0000055529-25-000013.md) | [11.0 d](/filings/0000055529-25-000026.md) | [2.2](/filings/0000055529-26-000009.md) | [3.0](/filings/0000055529-26-000009.md) | [1.4](/filings/0000055529-26-000009.md) | [4.9 d](/filings/0000055529-26-000020.md) | [3.1](/filings/0000055529-26-000035.md) | [2.4](/filings/0000055529-26-000009.md) | [0.7](/filings/0000055529-26-000009.md) | [3.4 d](/filings/0000055529-26-000020.md) | [1.7](/filings/0000055529-26-000035.md) |
| Diluted EPS | $ per share | [0.93](/filings/0000055529-24-000040.md) | [0.85](/filings/0000055529-25-000013.md) | not reported | [0.74](/filings/0000055529-25-000040.md) | [1.01](/filings/0000055529-25-000054.md) | [0.45](/filings/0000055529-26-000009.md) | not reported | [1.04](/filings/0000055529-26-000035.md) | [0.82](/filings/0000055529-25-000054.md) | [0.23](/filings/0000055529-26-000009.md) | not reported | [0.58](/filings/0000055529-26-000035.md) |
| Basic EPS | $ per share | [0.94](/filings/0000055529-24-000040.md) | [0.87](/filings/0000055529-25-000013.md) | not reported | [0.77](/filings/0000055529-25-000040.md) | [1.05](/filings/0000055529-25-000054.md) | [0.47](/filings/0000055529-26-000009.md) | not reported | [1.08](/filings/0000055529-26-000035.md) | [0.85](/filings/0000055529-25-000054.md) | [0.24](/filings/0000055529-26-000009.md) | not reported | [0.59](/filings/0000055529-26-000035.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | FY2024 (2024-04-30) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | FY2025 (2025-04-30) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | FY2026 (2026-04-30) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [13.7](/filings/0000055529-23-000029.md) | [21.3](/filings/0000055529-24-000009.md) | [23.3](/filings/0000055529-25-000026.md) | [24.2](/filings/0000055529-24-000031.md) | [26.0](/filings/0000055529-24-000040.md) | [9.5](/filings/0000055529-25-000013.md) | [14.9](/filings/0000055529-26-000020.md) | [19.5](/filings/0000055529-25-000040.md) | [12.6](/filings/0000055529-25-000054.md) | [8.2](/filings/0000055529-26-000009.md) | [10.0](/filings/0000055529-26-000035.md) | [8.2](/filings/0000055529-26-000035.md) |
| Current assets | $m | [90.9](/filings/0000055529-23-000029.md) | [96.2](/filings/0000055529-24-000009.md) | [96.8](/filings/0000055529-25-000026.md) | [92.7](/filings/0000055529-24-000031.md) | [96.4](/filings/0000055529-24-000040.md) | [109](/filings/0000055529-25-000013.md) | [118](/filings/0000055529-26-000020.md) | [117](/filings/0000055529-25-000040.md) | [114](/filings/0000055529-25-000054.md) | [104](/filings/0000055529-26-000009.md) | [105](/filings/0000055529-26-000035.md) | [104](/filings/0000055529-26-000035.md) |
| Total assets | $m | [122](/filings/0000055529-23-000029.md) | [126](/filings/0000055529-24-000009.md) | [135](/filings/0000055529-25-000026.md) | [132](/filings/0000055529-25-000040.md) | [134](/filings/0000055529-25-000054.md) | [189](/filings/0000055529-26-000009.md) | [195](/filings/0000055529-26-000020.md) | [193](/filings/0000055529-26-000035.md) | [189](/filings/0000055529-25-000054.md) | [176](/filings/0000055529-26-000009.md) | [178](/filings/0000055529-26-000035.md) | [176](/filings/0000055529-26-000035.md) |
| Current liabilities | $m | [38.7](/filings/0000055529-23-000029.md) | [42.1](/filings/0000055529-24-000009.md) | [40.8](/filings/0000055529-25-000026.md) | [36.7](/filings/0000055529-24-000031.md) | [36.5](/filings/0000055529-24-000040.md) | [50.2](/filings/0000055529-25-000013.md) | [53.7](/filings/0000055529-26-000020.md) | [50.5](/filings/0000055529-25-000040.md) | [45.8](/filings/0000055529-25-000054.md) | [48.8](/filings/0000055529-26-000009.md) | [48.4](/filings/0000055529-26-000035.md) | [47.2](/filings/0000055529-26-000035.md) |
| Total liabilities | $m | [78.3](/filings/0000055529-23-000029.md) | [81.0](/filings/0000055529-24-000009.md) | [78.6](/filings/0000055529-25-000026.md) | [74.5](/filings/0000055529-24-000031.md) | [73.8](/filings/0000055529-24-000040.md) | [127](/filings/0000055529-25-000013.md) | [128](/filings/0000055529-26-000020.md) | [125](/filings/0000055529-25-000040.md) | [117](/filings/0000055529-25-000054.md) | [103](/filings/0000055529-26-000009.md) | [101](/filings/0000055529-26-000035.md) | [98.6](/filings/0000055529-26-000035.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [35.0](/filings/0000055529-25-000013.md) | [34.7](/filings/0000055529-26-000020.md) | [34.4](/filings/0000055529-25-000040.md) | [32.3](/filings/0000055529-25-000054.md) | [16.3](/filings/0000055529-26-000009.md) | [15.1](/filings/0000055529-26-000035.md) | [13.8](/filings/0000055529-26-000035.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [3.0](/filings/0000055529-25-000013.md) | [3.0](/filings/0000055529-26-000020.md) | [3.0](/filings/0000055529-25-000040.md) | [3.0](/filings/0000055529-25-000054.md) | [5.0](/filings/0000055529-26-000009.md) | [5.0](/filings/0000055529-26-000035.md) | [5.0](/filings/0000055529-26-000035.md) |
| Short-term borrowings | $m | not reported | not reported | [3.1](/filings/0000055529-25-000026.md) | not reported | not reported | not reported | [1.0](/filings/0000055529-26-000020.md) | not reported | not reported | not reported | [0.1](/filings/0000055529-26-000020.md) | not reported |
| Shareholders' equity | $m | [42.1](/filings/0000055529-25-000013.md) | [44.1](/filings/0000055529-25-000013.md) | [54.8](/filings/0000055529-26-000020.md) | [56.0](/filings/0000055529-26-000009.md) | [59.3](/filings/0000055529-26-000009.md) | [60.8](/filings/0000055529-26-000009.md) | [64.5](/filings/0000055529-26-000035.md) | [67.1](/filings/0000055529-26-000035.md) | [69.9](/filings/0000055529-26-000009.md) | [70.7](/filings/0000055529-26-000009.md) | [74.7](/filings/0000055529-26-000035.md) | [75.0](/filings/0000055529-26-000035.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | Q4 FY2024 (2024-04-30) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | Q4 FY2025 (2025-04-30) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | Q4 FY2026 (2026-04-30) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [0.7 d](/filings/0000055529-24-000040.md) | [9.5 d](/filings/0000055529-25-000013.md) | [1.1 d](/filings/0000055529-25-000026.md) | [(0.8)](/filings/0000055529-25-000040.md) | [8.4 d](/filings/0000055529-25-000054.md) | [(2.3) d](/filings/0000055529-26-000009.md) | [9.4 d](/filings/0000055529-26-000020.md) | [5.8](/filings/0000055529-26-000035.md) | [(4.3) d](/filings/0000055529-25-000054.md) | [11.6 d](/filings/0000055529-26-000009.md) | [5.5 d](/filings/0000055529-26-000020.md) | [2.0](/filings/0000055529-26-000035.md) |
| Capital expenditure | $m | [1.3 d](/filings/0000055529-24-000040.md) | [0.5 d](/filings/0000055529-25-000013.md) | [1.0 d](/filings/0000055529-25-000026.md) | [0.3](/filings/0000055529-25-000040.md) | [0.7](/filings/0000055529-25-000054.md) | [0.7](/filings/0000055529-26-000009.md) | [0.5 d](/filings/0000055529-26-000020.md) | [0.8](/filings/0000055529-26-000035.md) | [1.6](/filings/0000055529-25-000054.md) | [0.7](/filings/0000055529-26-000009.md) | [0.9 d](/filings/0000055529-26-000020.md) | [0.8](/filings/0000055529-26-000035.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | [1.2 d](/filings/0000055529-25-000026.md) | not reported | not reported | not reported | [1.6 d](/filings/0000055529-26-000020.md) | [0.0](/filings/0000055529-26-000035.md) | not reported | not reported | not reported | [0.5](/filings/0000055529-26-000035.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-10-31) | Q3 FY2023 (2023-01-31) | Q1 FY2024 (2023-07-31) | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [2,830](/filings/0000055529-23-000029.md) | [2,911](/filings/0000055529-24-000009.md) | [2,885](/filings/0000055529-24-000031.md) | [2,931](/filings/0000055529-24-000040.md) | [2,965](/filings/0000055529-25-000013.md) | [2,967](/filings/0000055529-25-000040.md) | [2,974](/filings/0000055529-25-000054.md) | [2,995](/filings/0000055529-26-000009.md) | [2,963](/filings/0000055529-26-000035.md) | [2,990](/filings/0000055529-25-000054.md) | [2,983](/filings/0000055529-26-000009.md) | [2,921](/filings/0000055529-26-000035.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 2,895,347 at 2026-09-08, from the cover of the [10-Q filed 2026-09-11](/filings/0000055529-26-000035.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.